Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2417-2428
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2417
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2417
Figure 1 Schematic representation of some major miRNAs upregulated in serum after hepatocellular carcinoma occurrence.
Noteworthy, some of them (mir-122 and mi-R34a) display a tumor suppressor effect and represent not only a diagnostic target, but have been proposed in novel therapeutic approaches (Figure was created using BioRender.com). HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; LNA: Locked nucleic acid; MSC: Mesenchymal stem cell.
- Citation: Badami E, Busà R, Douradinha B, Russelli G, Miceli V, Gallo A, Zito G, Conaldi PG, Iannolo G. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World J Gastroenterol 2022; 28(22): 2417-2428
- URL: https://www.wjgnet.com/1007-9327/full/v28/i22/2417.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i22.2417